Home > Publications

Publications

Articles:

DUCROQ J., MOHA OU MAATI H., GUILBOT S., DILLY S., LAEMMEL E., PONS-HIMBERT C., FAIVRE J.F., BOIS P., STUCKER O.,
LE GRAND M. (2010)
Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation : a key role for IKs. British Journal of Pharmacology. Brit. J. Pharmacol., 159, 93–101.

DUCROQ J., PRINTEMPS R., GUILBOT S., GARDETTE J, SALVETAT C., LE GRAND M. (2007).
Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies. J. Pharmacol Toxicol Methods. 56: 159-70.

DUCROQ J., PRINTEMPS R., LE GRAND M. (2005).
Additive effects of ziprasidone and D,L-sotalol on the action potential in rabbit Purkinje fibres and on the hERG potassium current. J. Pharmacol Toxicol Methods. 52: 115-22.

Abstracts:

BILLIALD S., BRUNET S., HERBELLES C., DELPY E., DUCROQ J., PRINTEMPS R., TORDJMAN C. (2009).
Evaluation of the cardiac safety of new antidepressant drugs : predictivity of a combined in vitro and in vivo approach. J Pharmacol. Toxicol. Methods. (In press).

MOHA OU MAATI H., DUCROQ J., RIVET J., FAIVRE J.F., LE GRAND M., BOIS P.(2008).
Curcumin blocks the recombinant human cardiac KCNQ1/KCNE1 channels (IKs) stably expressed in HEK 293 cells. Congrès de Physiologie, de Pharmacologie et de Thérapeutique, Clermont-Ferrand, France, 9-11 Avril 2008. Fund. Clin. Pharmacol., 22 (Suppl. 1).

DUCROQ J., STUCKER O., PONS-HIMBERT C., MERCADIEU L., DILLY S., CROSS M., LE GRAND M (2008).
Acute protective effects of dexrazoxane during doxorubicin perfusion in isolated guineapig hearts. SPS meeting, Edimbourg, Ecosse, 18-21 Septembre 2007. J. Pharmacol Toxicol Methods., 163.

DUCROQ J., PRINTEMPS R., GUILBOT S., SALVETAT C., LE GRAND M (2007).
In vitro models to complete hERG channel assay in preclinical cardiac safety pharmacological studies. Congrès de Physiologie, de Pharmacologie et de Thérapeutique, Toulouse, France, 11-13 Avril 2007. Fund. Clin. Pharmacol., 21 (Suppl. 1).

DUCROQ J., PAJEAU P., PRINTEMPS R., LE GRAND M. (2004).
Ziprasidone increases the proarrhythmic risk after a d,l-sotalol pre-treatment in rabbit Purkinje fibres. EPHAR, Porto, Portugal, 14-16 Juin 2004. Fund. Clin. Pharmacol., 18 (Suppl. 1), p.115.

DUCROQ J., PAJEAU P. & LE GRAND M. (2003).
Electrophysiological effects of ziprazidone on the action potential parameters of rabbit Purkinje fibres. 20^ème Congrès du Groupe de Réflexion pour la Recherche Cardiovasculaire, Grenoble, France, 15-16 Avril 2003. Arch. Mal. Coeur Vaiss., 96 p.403.